- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01109576
Workshops for Veterans With Vision and Hearing Loss (DSLW)
August 28, 2015 updated by: US Department of Veterans Affairs
Pilot Study: Self Management Groups for Veterans With Dual Sensory Loss
This is a pilot study of workshops to help Veterans with both vision and hearing loss live a happier, fuller and less stressful life.
The results will be used to guide the development of a large scale clinical trial.
Study Overview
Detailed Description
This pilot study will enrolled 13 Veterans with Dual Sensory Loss (DSL), age 65 to over 89.
The project headquarters in the Portland Oregon Veterans Affairs Medical Center will be tasked with the development of the workshops and writing of a Curriculum and Procedures Manual.
The Atlanta VAMC research collaborators enrolled the 13 Veterans.
Staff turnover reduced time available for enrollment and data collection.
We therefore eliminated the original comparison group design and this study had only one experimental intervention arm and no control intervention or other arm.
Veterans were chronologically enrolled who responded to recruitment letters and who passed telephone and onsite screening.
The intervention consisted of six weekly two hour workshops providing information, skills training and exercises about self-managing DSL effects on daily life.
Preliminary effectiveness data was collected and analyzed, and a large scale clinical trial will be proposed as a followup to explore the efficacy of this management approach.
This study data tracked pre and post intervention within subject changes.
Study Type
Interventional
Enrollment (Actual)
13
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Georgia
-
Decatur, Georgia, United States, 30033
- Atlanta VA Medical and Rehab Center, Decatur
-
-
Oregon
-
Portland, Oregon, United States, 97201
- VA Portland Health Care System, Portland, OR
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
55 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Veteran;
- Vision loss > 20/70 better eye;
- Hearing loss > 40 decibels better ear;
- Cognition Within Normal Limits (WNL);
- No behavioral flag or psychiatric diagnosis;
- Documented psychosocial restrictions secondary to vision and hearing loss
Exclusion Criteria:
- Vision and/or hearing can be corrected by surgical or pharmacological treatment;
- Requires use of sign language interpreter
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: DSL workshop participants
Three to five Veterans with DSL.
|
A series of 6 weekly 2 hour interactive workshops for Veterans with age-related Dual Sensory Loss that provide instruction, skills training, exercises and facilitated interaction among peers.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Profile of Mood States Total Score.
Time Frame: Change in Profile of Mood States Score from Baseline to 8 Weeks
|
The change in Profile of Mood States total score is defined as the 8 week follow-up total score minus the baseline POMS total score.
The scale measures change in mood states before and after treatment.
The change score can range from -232 to 232, with negative values indicating greater reduction in emotional distress.
|
Change in Profile of Mood States Score from Baseline to 8 Weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Mitchel Turbin, PhD, Veterans Health Administration (VHA)
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2011
Primary Completion (ACTUAL)
July 1, 2012
Study Completion (ACTUAL)
August 1, 2013
Study Registration Dates
First Submitted
April 19, 2010
First Submitted That Met QC Criteria
April 22, 2010
First Posted (ESTIMATE)
April 23, 2010
Study Record Updates
Last Update Posted (ESTIMATE)
September 29, 2015
Last Update Submitted That Met QC Criteria
August 28, 2015
Last Verified
August 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- C7460-P
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Deafness
-
RWTH Aachen UniversityAdvanced BionicsCompletedDeafness, Bilateral | Deafness Unilateral | Deafness Congenital | Deafness, AcquiredGermany
-
Oticon MedicalCompletedUnilateral Deafness | Bone Conduction Deafness | Mixed Hearing Loss | Middle Ear DeafnessNetherlands
-
Oticon MedicalCompletedUnilateral Deafness | Bone Conduction Deafness | Mixed Hearing Loss | Middle Ear DeafnessNetherlands
-
Radboud University Medical CenterCochlearRecruitingDeafness, Bilateral | Deafness Neurosensory | Deafness PermanentNetherlands
-
University of North Carolina, Chapel HillMed-El CorporationRecruitingHearing Loss | Congenital Hearing Loss | Hearing Loss, Unilateral | Single Sided Deafness | Unilateral Deafness | Deafness One EarUnited States
-
Dr. Daniel LeeUniversity of Wisconsin, MadisonTerminatedTotal Unilateral Deafness | Unilateral Partial DeafnessUnited States
-
Hôpital RothschildCompletedDeafness; Perception, Bilateral
-
Clinica Universidad de Navarra, Universidad de...University Hospital, Montpellier; University Hospital, Toulouse; Asociacion Instituto... and other collaboratorsUnknownCongenital Deafness | Suspicion of Congenital DeafnessFrance
-
Hospices Civils de LyonCompleted
-
University of Colorado, DenverNational Institute on Deafness and Other Communication Disorders (NIDCD); University...CompletedCongenital Sensorineural DeafnessUnited States
Clinical Trials on DSL Workshop
-
Instituto de Investigación Sanitaria de la Fundación...Completed
-
University of WaterlooCompletedPsychological DistressCanada
-
Johns Hopkins Bloomberg School of Public HealthNational Institute on Drug Abuse (NIDA)CompletedDepression | HIV | Drug UseUnited States
-
Observatoire Regional de la Sante Provence-Alpes-Côte...University of Bordeaux; University of Avignon; Institut National de Recherche... and other collaboratorsCompletedNutrition, HealthyFrance
-
University of ArizonaCompletedStress | Stress, Psychological | Stress Reaction | Adjustment | Adjustment, Emotional | Adjustment, Social
-
University of TorontoCompleted
-
University Hospital, AngersUnknownAlzheimer Disease | Impaired Cognition | Gait ApraxiaFrance
-
Loma Linda UniversityCompleted
-
Hospital de Clinicas de Porto AlegreCompletedType 2 Diabetes MellitusBrazil